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Abstract
Background: In humans, convulsive diseases such as temporal lobe epilepsy are usually accompanied by learning and memory
impairments. In recent years, the role of gap junction channels as an important target of antiepileptic drugs has been studied and
discussed. Quinine, as a gap junction blocker of connexin 36, can abolish ictal epileptiform activity in brain slices.
Objectives: The role of quinine in memory retrieval in pentylenetetrazole (PTZ)-kindled rats was examined using a step-through
passive avoidance task.
Methods: Forty rats were used in this experimental study in groups of 10 animals. Quinine (15, 30, and 60 mg/kg, i.p.) and PTZ (35
mg/kg, i.p.) were injected into the rats before the start of the learning test. Then, retention tests were conducted after the treatments
ended.
Results: Quinine could attenuate seizure severity at doses of 15, 30 and 60 mg/kg compared with the control at the beginning of the
kindling experiment by lowering the mean seizure stages (P < 0.01, P < 0.001, P < 0.001). Quinine at doses of 15 and 30 mg/kg could
significantly increase memory retrieval compared with the control in the retention test 24 and 48 hours after training (P < 0.05).
Quinine at a dose of 60 mg/kg increased latency to enter the dark chamber 24 and 48 hours after training (P < 0.001). The results of
the retention test one and two weeks after training of quinine were not significant (P > 0.05).
Conclusions: Quinine may decrease the severity of seizure and improve the memory retrieval of animals by inhibiting the gap
junction channel. However, further studies are needed to evaluate the molecular mechanism underlying the effects of quinine.
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1. Background
Epilepsy is a major focus in the study of neurological
disorders. The incidence of epilepsy in the general popu-
lation is 45/100,000 (1). The pentylenetetrazole (PTZ)- kin-
dling model is a suitable model to show post abnormal-
ity of seizure and can be used to find useful treatments for
cognitive impairment in human epilepsy (2). Memory im-
pairment has been reported in patients with temporal lobe
epilepsy (TLE) (3).
Several studies showed that chemical kindling in-
duced by PTZ could impair memory retrieval (4-8). Com-
munication of neuron via gap junction channels has
been considered as an important mechanism in synchro-
nizing neurons in different conditions (9-12). In recent
years, the role of glial connexins (Cxs) and pannexins
(Panxs), proteins that form gap junctions and membrane
hemichannels (connexins) and hemichannels (pannex-
ins), in epilepsy has been discussed. The gap junction
seems to be involved in seizure activity (13). Abnormal
synchronization of neurons has been determined to occur
during epilepsy. Thus, gap junction blockers could inhibit
seizure, and openers could enhance it (14, 15). Gap junction
channels play a role in synchronizing human neocortical
networks and may implement epileptiform activity in fo-
cal cortical dysplasia (16). Quinine, an anti-malarial drug,
specifically blocks Cx36 and with lesser potency than Cx50
in mammalian cells (17). Quinine could increase the behav-
ioral stimulant effect of cocaine in mice and seems to play
a role in increasing the clearance of dopamine (18). It in-
hibited both electrophysiological parameters, such as am-
plitude and frequency of spike, and behavioral symptoms
of epilepsy (19). Gap junctions responsible for electrotonic
coupling between neurons and astrocytes and synchro-
nization of epileptoidal discharges are also considered as
a potential target for future antiepileptic drugs (20). The
results on the quaternary derivative N-benzylquininium
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of quinine indicated that modulating the gating of loop
caused the blocking of the gap junction channel rather
than its inhibition (21).
2. Objectives
This study aimed to find the possible effects of quinine
on memory retrieval in chemical kindling induced by PTZ
in rats.
3. Methods
3.1. Animals
Male Wistar rats (250 - 300 g) were obtained from the
Razi institute (Karaj, Iran) and housed under standard lab-
oratory conditions. They were kept at a constant room tem-
perature (21 ± 2 °C) under a normal 12 light: 12 dark cycle
with free access to food and water. All animal experiments
were conducted in accordance with the european commu-
nities council directive of November 24, 1986 (86/609/EEC)
to minimize the number of animals and their suffering.
3.2. Chemicals
Quinine anhydrous hydrochloride and PTZ were pur-
chased from Sigma. PTZ was dissolved in a physiological
saline solution, and quinine was dissolved in 0.8% (v/v)
Tween 80.
3.3. Experiments
Forty rats were used in this experimental study in
groups of 10 animals. In group one, saline was adminis-
trated 30 minutes prior to the injection of PTZ (35 mg/kg,
i.p., 9 injections total). In the other three groups, quinine
at doses of 10, 30, 60 mg/kg was administered 30 minutes
before PTZ every other day (35 mg/kg, i.p., 9 injections to-
tal), respectively. All injections were administrated every
other day. After the administration of drugs, the convul-
sive behavior of animals was recorded as Racine’s criteria
for 20 minutes (22): Stage 0= no changes, stage 1= facial and
ear movements and facial twitching, stage 2= myoclonic
convulsions, stage 3= myoclonic convulsions with rearing,
stage 4= clonic convulsions and loss of posture, and stage
5= generalized tonic-clonic seizures. Two days after the fi-
nal injection of PTZ, learning behavior of animals was eval-
uated using passive avoidance performance (23). The shut-
tle box consisted of two parts, a light compartment (20×
20× 30 cm) and a dark compartment (20× 20× 30 cm).
A guillotine door opening (6 × 6 cm) was formed on the
floor of the partition between the two compartments.
Food shock was produced by stainless steel grids (5 mm
in diameter) placed at 1 cm intervals on the floor of the dark
compartment. Animals were habituated in the experimen-
tal room for at least 30 minutes. The acquisition trial was
conducted 30 minutes after the habituation trial. Each an-
imal was placed in the light compartment, and the guillo-
tine door was opened after 5 seconds. Immediately, the an-
imal entered the dark compartment, the door was closed,
and a foot shock (50 HZ, 5 seconds, 0.2 mA intensity) was de-
livered to the grid floor of the dark part. After 20 seconds,
the rat was removed from the apparatus and placed in its
home cage. The training was terminated when the rat re-
mained in the light compartment for 120 seconds consecu-
tively (24). The retention tests were performed 1, 2, 7, and 14
days after training to evaluate memory function. Each ani-
mal was placed in the light compartment, and the session
ended when the animal entered the dark compartment or
when it remained in the light compartment for 300 sec-
onds. In these sessions, no electric shock was given to the
animals (24).
3.4. Data Analysis
One-way ANOVA and the post-hoc Tukey test were used
for analyzing data and comparing all groups. P value of less
than 0.05 was considered significant.
4. Results
4.1. Pretreatment of Quinine in the Development of Kindling
Chronic administration of PTZ increased the severity of
clonic convulsion and caused animals to reach stage 4 dur-
ing the last days of injection. Administration of quinine
(15, 30, and 60 mg/kg) before the injection of PTZ changed
the development of the kindling. Quinine at doses of 15, 30,
and 60 mg/kg could significantly reduce the mean seizure
stage during the 9 kindling injections compared with the
control (P < 0.01, P < 0.001, P < 0.001) (Figure 1).
Administration of quinine induced a significant in-
crease in memory retrieval compared with the controls.
Quinine at doses of 15 and 30 mg/kg significantly increased
latency to enter the dark chamber compared with the con-
trol 24 and 48 hours after training (P < 0.05) (Table 1). Qui-
nine at a dose of 60 mg/kg increased latency to enter the
dark chamber 24 and 48 hours after training (P < 0.001)
(Table 1). Quinine also increased memory retrieval one and
two weeks after training, but this effect was not significant.
5. Discussion
Our results indicate that quinine has anticonvulsant
activities in the PTZ kindling model. Pretreatment with
quinine at doses of 15, 30, and 60 mg/kg attenuated seizure
severity from the beginning of the kindling procedure by
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Table 1. Effects of Quinine (15, 30, and 60 mg/kg) on Step-Through Latency in Ratsa , b
Day Control Q15 Q30 Q60
1 38.9± 8.20 203.30± 61c 213± 56c 251± 48.20d
2 52.7± 28 209.20± 43c 210± 56c 300± 0.2d
7 125.6± 31 272.30± 27 89.30± 36 208.3± 58
14 68.6± 34 126.60± 58 99.30± 45 203.2± 61
aValues are expressed as mean± SEM, n = 10, Tukey-Kramer test.
bPassive avoidance learning tests were performed 24 hours, 48 hours, 1 week, and 2 week after training.
cP < 0.05.
dP < 0.001 compared with the same-day saline group.
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Figure 1. Effects of the repeated administration of quinine (15, 30, and 60 mg/kg)
on the development of PTZ-induced kindling (35 mg/kg, i.p., 9 injections total) com-
pared with the control. Data represent mean seizure stages± SEM, n = 10.
lowering the mean seizure stage. In this study, adminis-
tration of quinine before the injection of PTZ increased
memory retrieval in rats. Quinine at doses of 10, 30, and
60 mg/kg significantly enhanced memory retrieval in the
first and second retention tests compared with the control.
Our previous studies showed that quinine could inhibit
both induction and duration of seizure activity induced
by PTZ in animals (25, 26). Similarly, our previous data in-
dicated that quinine such as carbenoxolone has anticon-
vulsant effects on the PTZ model, and that pretreatment
with different doses of trimethylamine (TMA), a gap junc-
tion channel opener (i.c.v.), attenuated the anticonvulsant
effects of quinine on the latency and duration of general-
ized tonic-clonic seizure (25, 27). TMA could open the gap
junctions as a result of intracellular alkalinization (28, 29).
Consistent with these studies, gap junction openers exac-
erbate seizure activity (30, 31). Quinine was shown to close
the gap junction channels in a reversible, concentration-
dependent, and connexin-specific manner at an intracel-
lular binding site (17). Administration of quinine into
the entorhinal cortex in epileptic animals induced by 4-
aminopyridine could reduce the amplitude and frequency
of the discharge trains. The proepileptic effect of TMA on
epileptiform activity was suggested to depend on the time
and route of drug administration (32). As a gap junction
blocker, quinine has been recently shown to decrease the
mean number of fast ripples (FRs, 250-600 Hz) and the
mean number of oscillation cycles per FR event in the hip-
pocampus. FRs are considered potential biomarkers for
epilepsy, and FRs can be observed in TLE and in patients
with this pathology (33).
Quinine decreased the frequency and amplitude of
spikes. It also reduced the score of epileptic behavior in
the generalized epileptiform activity of penicillin (19). By
preventing the gap junction between neurons, quinine
was considered to inhibit convulsion in an in vitro study
(19). Thus, by inhibiting the activity of the gap junction
channel, quinine may dose-dependently reduce the sever-
ity of seizures and enhance memory performance in kin-
dled rats. However, this enhancement did not seem to
change by repeating the retention test in this study.
Two other possibilities were discussed for the anticon-
vulsive effects of quinine on PTZ-induced seizures in mice.
First, quinine seems to enhance the threshold of seizure
by inhibiting dopamine activity. Second, stability of neu-
ral membrane may be increased by increasing the perme-
ability of the potassium channel (34). Nevertheless, qui-
nine could prevent memory impairment associated with
epilepsy in animals through its anticonvulsant effects. Qui-
nine may dose-dependently reduce seizure and improve
memory retrieval by blocking the gap junction channel.
However, quinine seems to be more effective in close mem-
ory than in distant memory. Structure activity studies of
quinine can be useful to the synthesis of quinine-based
derivatives, which are effective in the treatment of seizure
disorders and memory dysfunction. Further studies are
needed to evaluate the molecular mechanisms of quinine
during PTZ kindling.
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